Ocumetra Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.01M

  • Investors
  • 6

Ocumetra General Information

Description

Developer of a digital healthcare platform intended to support evidence-based and personalized clinical decision support by eyecare professionals. The company develops a platform with web-based data tools to make complex clinical information accessible to practitioners and provides the evidence base to inform critical treatment decisions, enabling patients with communication and promoting health outcomes for those at risk of blindness or myopia.

Contact Information

Website
www.ocumetra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Greenway Hub, Grangegorman
  • Lower TU Dublin
  • Dublin
  • Ireland
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, HealthTech
Corporate Office
  • Greenway Hub, Grangegorman
  • Lower TU Dublin
  • Dublin
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocumetra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 27-Jul-2024 $3.01M Completed Generating Revenue
2. Early Stage VC 20-Dec-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Ocumetra’s complete valuation and funding history, request access »

Ocumetra Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
cumulative redeemable convertible preference shares
Ordinary 4,385 $0.010834 $61.77 $61.77 0x $61.77 7.09%
To view Ocumetra’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ocumetra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital healthcare platform intended to support evidence-based and personalized clinical decision support
Decision/Risk Analysis
Dublin, Ireland
13 As of 2025

Singapore, Singapore
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ocumetra Competitors (1)

One of Ocumetra’s competitors is Plano, a Venture Capital-Backed company based in Singapore, Singapore.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Plano Venture Capital-Backed Singapore, Singapore
You’re viewing 1 of 1 competitors. Get the full list »

Ocumetra Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Ocumetra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202414104-D0 A system and method of analyzing the refractive risk of an eye based on anatomical features Inactive 25-Sep-2024
WO-2026068658-A1 A system and method of analyzing the refractive risk of an eye based on anatomical features Pending 25-Sep-2024
EP-4120287-A1 A system and method of determining and analysing the ocular biometric status of a patient Pending 20-Dec-2019
US-20230036691-A1 A system and method of determining and analysing the ocular biometric status of a patient Active 20-Dec-2019
US-12471769-B2 System and method of determining and analysing the ocular biometric status of a patient Active 20-Dec-2019 A61B3/0025
To view Ocumetra’s complete patent history, request access »

Ocumetra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ocumetra Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Furthr VC Venture Capital Minority
FYi Eye Care E-Commerce PE-Backed Company Minority
Topcon Healthcare Solutions Corporation Minority
Enterprise Ireland Growth/Expansion Minority
Ocuco PE-Backed Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Ocumetra FAQs

  • When was Ocumetra founded?

    Ocumetra was founded in 2020.

  • Where is Ocumetra headquartered?

    Ocumetra is headquartered in Dublin, Ireland.

  • What is the size of Ocumetra?

    Ocumetra has 13 total employees.

  • What industry is Ocumetra in?

    Ocumetra’s primary industry is Decision/Risk Analysis.

  • Is Ocumetra a private or public company?

    Ocumetra is a Private company.

  • What is the current valuation of Ocumetra?

    The current valuation of Ocumetra is .

  • What is Ocumetra’s current revenue?

    The current revenue for Ocumetra is .

  • How much funding has Ocumetra raised over time?

    Ocumetra has raised $3.58M.

  • Who are Ocumetra’s investors?

    Furthr VC, FYi Eye Care E-Commerce, Topcon Healthcare Solutions, Enterprise Ireland, and Ocuco are 5 of 6 investors who have invested in Ocumetra.

  • Who are Ocumetra’s competitors?

    Plano is a competitor of Ocumetra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process